Abbott Diabetes Care, Inc.

Abbott Diabetes Care, Inc. — FDA 510(k) Submissions

Abbott Diabetes Care, Inc. has submitted 37 FDA 510(k) premarket notifications since 2000, of which 37 received clearance as substantially equivalent to a predicate device.

The company's most frequent device categories include System, Test, Blood Glucose, Over The Counter, Integrated Continuous Glucose Monitoring System, Factory Calibrated, Not For Use With Automated Insulin Delivery Systems, Glucose Dehydrogenase, Glucose, Integrated Continuous Glucose Monitoring System, Factory Calibrated, Pump, Infusion, Insulin . Use the specialty filter in the sidebar to narrow results.